Leukaemia
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PUMA (Paediatric Osseous Marrow Assessment) (NCT03466944) | Institute of Cancer Research, United Kingdom | 2018-03-05 |
| High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant (NCT01941680) | University Hospital Center of Martinique | 2013-10-31 |
| Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) (NCT02310997) | University College, London | 2011-07-01 |
| Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia (NCT01313689) | Novartis Pharmaceuticals | 2011-04-14 |
| Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML (NCT00502385) | AstraZeneca | 2004-04-01 |
Track Leukaemia automatically
Every clearance here is in the API, with alerts when new ones post.